Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Anti-inflammatory potential of Astragalus polysaccharides: structural characteristics, mechanisms and clinical translation

Abstract

Astragalus polysaccharides (APS) are important bioactive macromolecules derived from Astragalus mongholicus Bunge, with potential anti-inflammatory properties. However, APS are structurally complex and highly heterogeneous natural polysaccharides and their structural characteristics, such as molecular weight, monosaccharide composition, glycosidic linkage types, and branching patterns, may all affect their biological activities. In addition, factors such as plant source, medicinal part, extraction and processing methods, degradation, and structural modifications can further contribute to structural differences among various APS preparations. Due to the complexity of the fine structure of polysaccharides and the limitations of current methods for structural characterization and functional validation, the relationship between the specific structural features of APS and their anti-inflammatory activity has not yet been fully elucidated. In recent years, research into the anti-inflammatory mechanisms of APS has continued to deepen, encompassing multiple regulatory levels such as inflammatory signaling, oxidative stress, cellular homeostasis, macrophage function, and the gut microbiota. Based on this, this review focuses on the potential links between the structural characteristics of APS and their anti-inflammatory activity, and comprehensively summarizes the anti-inflammatory mechanisms of APS and research progress in inflammation-related diseases. At the same time, given the significant variations in experimental design and the depth of validation among existing structure-activity relationship studies, this review conducts a tiered evaluation of relevant structure-activity relationships and anti-inflammatory mechanisms based on specific APS preparations, taking into account the directness of evidence provided by different types of studies. By comparing the results of various studies, this review aims to further clarify the structural basis of the anti-inflammatory effect of APS and provide a reference for further research and development. Furthermore, this review discusses the pharmacokinetic characteristics of APS, novel delivery strategies, and the major challenges facing clinical translation.

Related

  1. Astragalus Polysaccharides Alleviate Inflammatory Damage in Murine Rheumatoid Arthritis by Modulating Th17/Treg Balance via the Gut–Joint Axis
    Pu Yao, Jing Huang, Wenying Liu +2
    MoleculesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  2. The role of astragalus polysaccharides in alleviating transport stress in piglets
    Peng Liu, Jinjiao Zuo, Hui Lu +1
    PLOS OnePeer-reviewedCC BY 4.0Full textCell biologyImmunologyPLOS
  3. GelMA‐Based Hydrogel Encapsulating Astragalus Polysaccharides and Umbilical Cord Mesenchymal Stem Cell Exosomes Promotes Full‐Thickness Skin Wound Healing
    Jingwen Tian, Xiangjing Zhao, Jingxian Xie +5
    Chronic Diseases and Translational MedicinePeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMCEurope PMC
  4. Salmon bone-derived chondroitin sulfate nanogels for controlled delivery of curcumin: release behavior, structural characteristics and anti-inflammatory efficacy.
    Quang Van Ngo, Nguyen Chi Nguyen, Hong Thi Pham +3
    RSC advancesPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. Edible Mushroom Polysaccharides as Functional Food Ingredients for Metabolic Health: Preparation, Techno-Functional Behavior, and Requirements for Translation.
    Ming Chen, Ruifan Zou, Jie Chen +3
    Foods (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
BibTeX
@article{zhao2026antiinflammatory,
  title = {{Anti-inflammatory potential of Astragalus polysaccharides: structural characteristics, mechanisms and clinical translation}},
  author = {Xue Zhao and Haixin Ding and Bo Wang and Pengling Ge},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = nov,
  doi = {10.3389/fphar.2026.1999582},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1999582},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Anti-inflammatory potential of Astragalus polysaccharides: structural characteristics, mechanisms and clinical translation
AU  - Xue Zhao
AU  - Haixin Ding
AU  - Bo Wang
AU  - Pengling Ge
PY  - 2026
DA  - 2026/11/05
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1999582
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1999582
AB  - Astragalus polysaccharides (APS) are important bioactive macromolecules derived from Astragalus mongholicus Bunge, with potential anti-inflammatory properties. However, APS are structurally complex and highly heterogeneous natural polysaccharides and their structural characteristics, such as molecular weight, monosaccharide composition, glycosidic linkage types, and branching patterns, may all affect their biological activities. In addition, factors such as plant source, medicinal part, extraction and processing methods, degradation, and structural modifications can further contribute to structural differences among various APS preparations. Due to the complexity of the fine structure of polysaccharides and the limitations of current methods for structural characterization and functional validation, the relationship between the specific structural features of APS and their anti-inflammatory activity has not yet been fully elucidated. In recent years, research into the anti-inflammatory mechanisms of APS has continued to deepen, encompassing multiple regulatory levels such as inflammatory signaling, oxidative stress, cellular homeostasis, macrophage function, and the gut microbiota. Based on this, this review focuses on the potential links between the structural characteristics of APS and their anti-inflammatory activity, and comprehensively summarizes the anti-inflammatory mechanisms of APS and research progress in inflammation-related diseases. At the same time, given the significant variations in experimental design and the depth of validation among existing structure-activity relationship studies, this review conducts a tiered evaluation of relevant structure-activity relationships and anti-inflammatory mechanisms based on specific APS preparations, taking into account the directness of evidence provided by different types of studies. By comparing the results of various studies, this review aims to further clarify the structural basis of the anti-inflammatory effect of APS and provide a reference for further research and development. Furthermore, this review discusses the pharmacokinetic characteristics of APS, novel delivery strategies, and the major challenges facing clinical translation.
SN  - 1663-9812
ER  -